Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Lingappa, Jairam R; Baeten, Jared M; Wald, Anna; Hughes, James P; Thomas, Katherine K; Mujugira, Andrew; Mugo, Nelly; Bukusi, Elizabeth A; Cohen, Craig R; Katabira, Elly; +30 more... Ronald, Allan; Kiarie, James; Farquhar, Carey; Stewart, Grace John; Makhema, Joseph; Essex, Myron; Were, Edwin; Fife, Kenneth H; de Bruyn, Guy; Gray, Glenda E; McIntyre, James A; Manongi, Rachel; Kapiga, Saidi; Coetzee, David; Allen, Susan; Inambao, Mubiana; Kayitenkore, Kayitesi; Karita, Etienne; Kanweka, William; Delany, Sinead; Rees, Helen; Vwalika, Bellington; Magaret, Amalia S; Wang, Richard S; Kidoguchi, Lara; Barnes, Linda; Ridzon, Renee; Corey, Lawrence; Celum, Connie; Partners in Prevention HSV/HIV Transmission Study Team; (2010) Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet, 375 (9717). pp. 824-833. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(09)62038-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(09)62038-9

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar